European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma
| Autor: | Ali, Sahra, Camarero, Jorge, Hennik, Paulavan, Bolstad, Bjorg, Sommerfelt Grønvold, Maja, Syvertsen, Christian, Oddvar Strøm, Bjorn, Ökvist, Mats, Josephson, Filip, Keller-Stanislawski, Brigitte, Zafiropoulos, Nikolaos, Pean, Elias, Bergh, Jonas, da Rocha Dias, Silvy, Pignatti, Franscesco |
|---|---|
| Zdroj: | In ESMO Open 2020 5(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|